These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19571794)

  • 21. Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity.
    Bortolato M; Frau R; Piras AP; Luesu W; Bini V; Diaz G; Gessa G; Ennas MG; Castelli MP
    Neurotox Res; 2009 Apr; 15(3):232-45. PubMed ID: 19384596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional-specific changes in rat brain BDNF in a model of methamphetamine abuse.
    Iamjan SA; Veerasakul S; Reynolds GP; Thanoi S; Nudmamud-Thanoi S
    Neurosci Lett; 2024 Jul; 836():137880. PubMed ID: 38885757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.
    Kuczenski R; Everall IP; Crews L; Adame A; Grant I; Masliah E
    Exp Neurol; 2007 Sep; 207(1):42-51. PubMed ID: 17603040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hanson GR; Fleckenstein AE
    Synapse; 2013 Dec; 67(12):875-81. PubMed ID: 23893609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.
    Zolkowska D; Jain R; Rothman RB; Partilla JS; Roth BL; Setola V; Prisinzano TE; Baumann MH
    J Pharmacol Exp Ther; 2009 May; 329(2):738-46. PubMed ID: 19197004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system.
    Chiu VM; Schenk JO
    Curr Drug Abuse Rev; 2012 Sep; 5(3):227-42. PubMed ID: 22998621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
    Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
    Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats.
    Chandler CM; Nickell JR; George Wilson A; Culver JP; Crooks PA; Bardo MT; Dwoskin LP
    Biochem Pharmacol; 2024 Oct; 228():116189. PubMed ID: 38580165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal lead exposure enhances methamphetamine sensitization in rats.
    Clifford PS; Hart N; Thompson J; Buckman S; Wellman PJ; Bratton GR; Nation JR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):165-9. PubMed ID: 19433104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.
    Krasnova IN; Hodges AB; Ladenheim B; Rhoades R; Phillip CG; Cesena A; Ivanova E; Hohmann CF; Cadet JL
    Neurosci Res; 2009 Oct; 65(2):160-5. PubMed ID: 19559060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats.
    Le Cozannet R; Markou A; Kuczenski R
    Eur J Neurosci; 2013 Nov; 38(10):3487-95. PubMed ID: 24112125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity.
    Guilarte TR; Nihei MK; McGlothan JL; Howard AS
    Neuroscience; 2003; 122(2):499-513. PubMed ID: 14614914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
    Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW
    J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caudate-putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges.
    Kuczenski R; Segal DS
    Brain Res; 2001 Dec; 923(1-2):32-8. PubMed ID: 11743969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses.
    Segal DS; Kuczenski R
    Psychopharmacology (Berl); 1999 Feb; 142(2):182-92. PubMed ID: 10102771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.
    Myles BJ; Sabol KE
    Psychopharmacology (Berl); 2008 Jun; 198(3):313-22. PubMed ID: 18438647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
    Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.